Evaluating the cost-benefit profile of CPI stem cell therapy necessitates a comprehensive perspective. Proponents often stress the possibility for significant therapeutic benefits, especially in conditions where conventional treatments have proven inadequate. However, crucially important to consider the considerable financial expenditure associated